New device shows promise in type 2 diabetes treatment, says study
Gastric bypass surgery is known to a highly effective treatment of obesity and type 2 diabetes. But a new device could be little less invasive.
A newly-tested medical device called ‘Sleeveballoon’ mimics the effects of traditional bariatric surgery in rodents and produces impressive results on body weight, fatty liver and diabetes control, a new study has found.
As a device that combines a balloon with a connected sleeve, Sleeveballoon covers the initial parts of the small intestine. It is inserted into the stomach and bowel during a minimally invasive surgery under general anaesthesia.
For the study, published in the journal EBioMedicine, researchers compared the effects of the Sleeveballoon and traditional bariatric surgery on 30 rodents fed with a high-fat diet, achieving very similar results.